Arcadia Biosciences (RKDA) Expands GoodWheat™ Mac & Cheese with Nationwide Availability
-- Three flavor varieties fiber up the beloved boxed classic, delivering amazing taste with a Mac that’s good for your gut, plus the most fiber in the category --

(Photo: Business Wire)
Made with noodles crafted from Arcadia’s proprietary wheat grain, which is naturally higher in fiber and protein than traditional wheat, GoodWheat Mac & Cheese delivers the classic mac & cheese taste and texture the whole family loves, but healthier. GoodWheat Mac & Cheese has 12g of protein and is an excellent source of fiber with 4x the fiber of traditional boxed mac & cheese (8g per serving vs 2g in traditional mac). Available in three kid-approved flavors – Classic Cheddar, White Cheddar and Three Cheese – and made with real cheese from cows not treated with rBST, even the pickiest eaters will love this healthy take on a classic.
“With the growing popularity of mac & cheese, a multi-billion-dollar category and a family favorite, it’s the perfect next brand expansion for GoodWheat, on our mission to bring more fiber to the foods consumers love,” said Stan Jacot, president and CEO of Arcadia Biosciences. “By leveraging our signature,
Americans are grappling with a widespread fiber deficiency – and research shows that
GoodWheat Mac & Cheese is now available on Amazon in four different four-pack varieties for
About GoodWheat™
Sixteen years in the making, GoodWheat is a unique, breakthrough, better-for-you wheat grain that is naturally higher in fiber with nothing added. GoodWheat is
About Arcadia Biosciences, Inc.
Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating crops to provide high-value, healthy ingredients to meet consumer demands for healthier choices. With its roots in agricultural innovation, Arcadia cultivates next-generation wellness products that make everybody feel good. The company’s food and beverage products include GoodWheat™ pasta, pancake mixes and mac & cheese and Zola® coconut water. For more information, visit www.arcadiabio.com.
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to, the risks set forth in Arcadia’s Annual Report on Form 10-K for the year ended December 31, 2022 and other filings. These forward-looking statements speak only as of the date hereof, and Arcadia Biosciences, Inc. disclaims any obligation to update these forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240220088402/en/
TJ Schaefer
Chief Financial Officer
ir@arcadiabio.com
Source: Arcadia Biosciences, Inc.